Arthrospira Platensis.

Spirulina carries a meaningful amount of non-heme iron, which the gut absorbs poorly in its ferric state. Ascorbate reduces it to the ferrous form and holds it soluble at intestinal pH, raising uptake through DMT1.

Zinc and the non-heme iron in spirulina both cross the enterocyte through DMT1, so a large zinc dose taken in the same sitting lowers iron uptake. Separating the two by a few hours removes the competition.

Calcium taken in the same meal blunts non-heme iron absorption at the enterocyte, and it also raises gastric pH, which keeps iron in the poorly soluble ferric form. Spaced dosing preserves the iron spirulina contributes.

Most of the cobalamin in spirulina is pseudovitamin B12, a corrinoid analogue that binds human intrinsic factor poorly and does not serve as a cofactor for methionine synthase. A real B12 source is needed alongside it rather than instead of it.

Spirulina is one of the few non-seed sources of gamma-linolenic acid, the delta-6 desaturase product that sits upstream of dihomo-gamma-linolenic acid. Adding a concentrated GLA oil raises intake of the same intermediate to a measurable dose.

Spirulina carries beta-carotene and zeaxanthin as part of its light-harvesting apparatus, and these are cleaved by BCO1 into retinal. A supplemental carotenoid adds to the same provitamin A pool rather than acting through a separate route.

Spirulina contains phylloquinone, the same form supplied by a vitamin K1 supplement, and both feed gamma-carboxylation of clotting factors in the liver. Anyone tracking a steady vitamin K intake should count both sources.

The iron in spirulina is bound within phycobiliprotein and ferritin-like structures and arrives at modest amounts per serving. A defined iron dose alongside it gives a known intake instead of one that varies with the algal batch.

Both are dried microalgal biomasses that supply nonheme iron along with protein and pigment. A systematic review pooled in vivo work on the two and reported effects on iron status markers rather than on any clinical endpoint. Marker movement is not the same as an outcome. The review drew on animal and model data, so it grounds a plausible shared route and not a human effect.

Spirulina biomass contributes nonheme iron, which enters the same ferric-reduction and DMT1 route as an iron amino acid chelate. Total nonheme load from both sources therefore competes for one absorptive path rather than acting independently. The systematic review that included Arthrospira reported iron status markers in in vivo models, which is marker data, not a human outcome.

Tannins form insoluble complexes with nonheme iron before it reaches the enterocyte. The iron in spirulina is nonheme, so a tannin-rich intake taken at the same time lowers how much of it is available for absorption. This is a well-characterised interaction that needs no combination trial. Separating the two intakes in time is the ordinary way formulators and clinicians work around it.

EGCG carries galloyl groups that chelate ferric iron in the gut. Taken alongside a nonheme iron source such as spirulina biomass, it reduces the fraction available for uptake. The effect is on absorption of that meal, not on stored iron. Timing the two apart is the usual formulation answer.

Spirulina supplies water-soluble phycobiliproteins and carotenoids, while alpha-tocopherol works inside membranes. The two act in different phases, so they cover different compartments rather than duplicating each other. Antioxidant capacity assays read as markers of redox chemistry and do not by themselves describe a clinical result.

Selenoprotein glutathione peroxidase needs selenium in its active site to reduce hydroperoxides. Dietary antioxidants such as the phycobilins in spirulina scavenge radicals non-enzymatically and cannot substitute for that enzyme. The two mechanisms sit in series, which is why adequacy of the cofactor matters when a formula leans on antioxidant framing.

Glutathione is the main intracellular thiol buffer, while spirulina pigments act largely in the gut lumen and plasma compartment before absorption of their breakdown products. Support for one pool does not regenerate the other directly. Anything measured here is a redox marker rather than a functional endpoint.

Because zeaxanthin is already present in the biomass, a formula that also declares isolated zeaxanthin is stacking the same molecule from two sources. That matters for totalling the amount rather than for any interaction. Xanthophylls from either source share the same lipid-dependent absorption route.

Beta-carotene and zeaxanthin in dried spirulina need dietary lipid for micellar solubilisation. Taking the powder with no fat at all leaves the carotenoid fraction poorly absorbed while the protein fraction is unaffected. A lipid vehicle addresses solubilisation only and does not change the amount of pigment in the biomass.

A trial report examined spirulina supplementation against intestinal permeability and marker panels, which is the same domain probiotic work is usually framed in. The two have not been tested as a pair in the candidate literature. Permeability and inflammatory readouts are markers, so this is a shared measurement domain and not a demonstrated combined effect.

Spirulina biomass is roughly six-tenths protein by dry weight and supplies every indispensable amino acid, though with lower methionine and cysteine density than dairy protein. Combining the two raises the sulphur amino acid share of the blend. This is composition arithmetic and does not imply an effect beyond total protein and amino acid supply.

Spirulina biomass carries appreciable iron and other divalent minerals, which share transport capacity with copper at the enterocyte. A large mineral-dense load taken with isolated copper can reduce uptake of the smaller partner. The interaction is about the same dose window, not about long-term status by itself.